The Safety and Efficacy Test of Immuncell-LC to Treat Refractory Metastatic Colorectal Cancer

NCT03220984 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

BIOLOGICAL: Immuncell-LC intravenous infusion using a CIK cell agent

Sponsor

Gangnam Severance Hospital